Global Intravenous Solutions Market Revenue Grows at a CAGR of 9.60%

Straits Research released its highly anticipated report, “Global Intravenous Solutions Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 14.71 billion in 2025 and is anticipated to grow to USD 33.46 billion by 2034, growing at a CAGR of 9.60% from 2026-2034.

Market Dynamics

The intravenous solutions market is driven by expanding utilization of infusion based therapy across acute care, chronic disease management, and nutritional support pathways within hospitals and home care settings. Rising surgical volumes, longer inpatient stays for complex conditions, and broader adoption of parenteral nutrition for patients with compromised gastrointestinal function continue to sustain baseline demand for intravenous fluids and nutritional formulations. Increasing shift toward home based infusion therapy further supports market growth by extending intravenous treatment beyond institutional settings and integrating it into long-term care models. However, the market faces restraint from stringent regulatory oversight governing sterile manufacturing, quality assurance, and distribution of intravenous solutions, which increases production complexity and cost while limiting rapid capacity expansion. Maintaining contamination-free environments, compliance with pharmacopeial standards, and consistency across global supply chains places operational pressure on manufacturers, particularly when serving multiple regulated markets. In addition, vulnerability of intravenous solution supply chains to raw material shortages and transportation disruptions creates periodic availability challenges for healthcare providers. Despite these constraints, the market presents a clear opportunity through expansion of decentralized compounding and localized production facilities aligned with regional healthcare demand. Establishing hospital linked or regional sterile compounding units supports faster response to demand fluctuations, reduces dependency on long distance logistics, and improves supply continuity during disruptions. Growing adoption of structured home infusion programs also creates opportunities for manufacturers to develop packaging formats and formulations tailored for outpatient and home administration. Together, these dynamics position the intravenous solutions market for sustained expansion as healthcare systems increasingly rely on infusion based therapy to support evolving models of patient care.

Market Highlights

• Type: Based on Type, the peripheral parenteral nutrition segment is anticipated to register the fastest CAGR of 10.12% during the forecast period.
• Composition: Based on Composition, single-dose amino acids dominated the market with a revenue share of 32.34% in 2025.
• Age Group: Based on Age Group, the geriatric segment dominated the market with a revenue share of 49.24% in 2025.
• End Use: Based on End Use, the home segment dominated the market with a revenue share of 59.12% in 2025.
• Regional Insights: North America held a dominant share of the global market, accounting for 42.14% in 2025.

Market Segments

1. By Type (2026-2034)
   1. Total Parenteral Nutrition
   2. Peripheral Parenteral Nutrition
2. By Composition (2026-2034)
   1. Carbohydrates
   2. Vitamins & Minerals
   3. Single-dose Amino Acids
   4. Parenteral Lipid Emulsion
   5. Others
3. By Age Group (2026-2034)
   1. Pediatric
   2. Adults
   3. Geriatric
4. By End Use (2026-2034)
   1. Home
   2. Hospitals
   3. Infusion Centers